Clinical Trials Browser

Withdrawn × Cisplatin × Gynecologic × Clear all

NCT05998941 2023-11-22

A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer

Phase 2 Withdrawn

Uterine Cervical Neoplasms

NCT03834571 2022-06-21

Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women

Phase 2 Withdrawn

Uterine Cervical Neoplasms, HIV Infections

NCT04806945 2022-05-05

A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer

Phase 3 Withdrawn

Uterine Cervical Neoplasms

NCT01019278 2020-04-03

Proton Beam Radiation Therapy and Cisplatin in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer and Positive Lymph Nodes

Phase 2 Withdrawn

Uterine Cervical Neoplasms

NCT00257829 2018-12-03

Improving Tumor Oxygenation in Cervical Cancer

Phase 2 Withdrawn

Uterine Cervical Neoplasms

NCT00428194 2017-11-29

Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer

Phase 1 Withdrawn

Uterine Cervical Neoplasms

NCT01138137 2017-04-21

N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer

Phase 1 Withdrawn

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00967928 2014-02-14

Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer

Phase 1 Withdrawn

Uterine Cervical Neoplasms

NCT00942838 2013-07-24

WAR

Phase 1 Withdrawn

Neoplasms, Ovarian Neoplasms

NCT00137358 2013-01-24

Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer

Phase 1 Withdrawn

Uterine Cervical Neoplasms, Neoplasms

NCT00057928 2012-06-13

S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer

Phase 3 Withdrawn

Uterine Cervical Neoplasms